Elanco Animal Health Incorporated Common Stock (ELAN)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 9,900
- Market Cap
- $13.2B
About Elanco Animal Health Incorporated Common Stock
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
SentiSense also tracks daily options readings for Elanco Animal Health Incorporated Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Elanco Animal Health Incorporated Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.